A single injection of 200 or 300 μCi (e.g., 7.4–11.1 MBq) of 90Y-αGPC3 significantly halted or reversed tumor growth, as evidenced by stable or reduced AFP levels and significantly lighter tumor-bearing livers compared to controls. The gene discussed is AFP; the disease is neoplasm.